z-logo
open-access-imgOpen Access
Multivalvular Disease: Percutaneous Management in 2019 and Beyond
Author(s) -
Magdalena Erlebach,
Rüediger Lange
Publication year - 2019
Publication title -
interventional cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.832
H-Index - 11
eISSN - 1756-1477
pISSN - 1756-1485
DOI - 10.15420/icr.2019.13.r1
Subject(s) - medicine , percutaneous , disease , intensive care medicine , disease management , population , surgery , environmental health , parkinson's disease
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here